Global Sacral Nerve Stimulation Market Report and Forecast 2023-2031

Global Sacral Nerve Stimulation Market Report and Forecast 2023-2031
Global Sacral Nerve Stimulation Market Outlook
The value of the global sacral nerve stimulation market was USD 1210.25 million in 2022, driven by the by increasing prevalence of urinary and faecal incontinence across the globe across the globe. The market is expected to grow at a CAGR of 12.50% during the forecast period of 2023-2031 to reach value of USD 3493.41 million by 2031.

Sacral Nerve Stimulation: Introduction

Sacral nerve stimulation (SNS) is a medical procedure that uses electrical impulses to stimulate the sacral nerves, which are located at the base of the spinal cord. This treatment is used to treat a variety of conditions such as urinary and faecal incontinence, chronic pelvic pain, and other lower urinary tract symptoms. SNS involves the implantation of a small device, which is placed under the skin near the buttocks and connected to a thin wire that runs to the sacral nerves. The device delivers electrical impulses that help regulate the function of the bladder and other pelvic organs. SNS is considered a minimally invasive procedure and can be an effective alternative for patients who have not responded to other treatments.

Sacral Nerve Stimulation: Application and Uses

Sacral nerve stimulation (SNS) is a medical treatment used to manage several conditions, including urinary and faecal incontinence, pelvic pain, and constipation. The treatment involves implanting a small device under the skin near the sacral nerve in the lower back. This device sends electrical impulses to the sacral nerve, which helps to regulate bladder and bowel function and reduces pelvic pain.

SNS is primarily used for the treatment of urinary and faecal incontinence. In patients with urinary incontinence, SNS can improve bladder control by decreasing detrusor overactivity and increasing bladder capacity. In patients with faecal incontinence, SNS can improve anal sphincter function and reduce episodes of faecal leakage. SNS has also been used to treat chronic pelvic pain and constipation in certain patient populations.

Global Sacral Nerve Stimulation Market Segmentations

Market Breakup by Product

• Implantable SNS Devices
• External SNS Devices

Market Breakup by Type

• Electrical Muscle Stimulation
• Transcutaneous Electrical Nerve Stimulation

Market Breakup by Application

• Urinary and Faecal Incontinence
• Urge Incontinence
• Chronic Anal Fissure
• Others

Market Breakup by End User

• Hospitals
• Ambulatory Surgical Centres
• Others

Market Breakup by Region

North America

• United States of America
• Canada

Europe

• United Kingdom
• Germany
• France
• Italy
• Others

Asia Pacific

• China
• Japan
• India
• ASEAN
• Australia
• Others

Latin America

• Brazil
• Argentina
• Mexico
• Others

Middle East and Africa

• Saudi Arabia
• United Arab Emirates
• Nigeria
• South Africa
• Others

Global Sacral Nerve Stimulation Market Scenario

The global market for sacral nerve stimulation is expected to grow due to the increasing prevalence of urinary and faecal incontinence and the rising demand for minimally invasive procedures. The market is also driven by technological advancements, favourable reimbursement policies, and the growing awareness of the benefits of sacral nerve stimulation. The market is segmented by product type, application, end-user, and geography. The major players in the market include Medtronic, Boston Scientific, and Axonics Modulation Technologies.

Key Players in the Global Sacral Nerve Stimulation Market

The report gives an in-depth analysis of the key players involved in the global sacral nerve stimulation market. The companies included in the market are as follows:

• Medtronic
• Abbott Laboratories
• Axonics, Inc
• Boston Scientific Corporation
• St. Jude Medical
• Cyberonics
• Neuropace
• Synapse Biomedical
• Uroplasty Inc
• Codman And Shurtleff Inc
• IntraPace Inc

This product will be delivered within 5-7 business days.